These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 37092277)

  • 1. Prediction Models for Intravenous Immunoglobulin Resistance in Kawasaki Disease: A Meta-analysis.
    Kuniyoshi Y; Tsujimoto Y; Banno M; Taito S; Ariie T; Takahashi N; Tokutake H; Takada T
    Pediatrics; 2023 May; 151(5):. PubMed ID: 37092277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Japanese Kawasaki Disease Scoring Systems: Are they Applicable to the Iranian Population?
    Edraki MR; Mohammadi H; Mehdizadegan N; Ghorashi M; Amoozgar H; Borzouee M; Ajami G; Keshavarz K; Dehghani E; Bahrami R
    Arch Iran Med; 2020 Jan; 23(1):31-36. PubMed ID: 31910632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of IVIG resistance predictive models in Kawasaki disease.
    Kaya Akca U; Arslanoglu Aydin E; Aykan HH; Serin O; Sag E; Demir S; Atalay E; Kasap M; Batu ED; Karagoz T; Bilginer Y; Ozen S
    Pediatr Res; 2022 Feb; 91(3):621-626. PubMed ID: 33753891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The factors affecting the disease course in Kawasaki disease.
    Arslanoglu Aydin E; Ertugrul I; Bilginer Y; Batu ED; Sonmez HE; Demir S; Arici ZS; Sag E; Alehan D; Ozen S
    Rheumatol Int; 2019 Aug; 39(8):1343-1349. PubMed ID: 31139951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of Kawasaki disease risk scoring systems to the Turkish population.
    Öztarhan K; Varlı YZ; Aktay Ayaz N
    Anatol J Cardiol; 2020 Aug; 24(2):97-106. PubMed ID: 32749248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Verification of risk scores to predict i.v. immunoglobulin resistance in incomplete Kawasaki disease.
    Kanamitsu K; Kakimoto H; Shimada A; Nakata Y; Ochi H; Watanabe H; Iwasaki Y; Tokorodani C; Kanazawa A; Maruyama H; Miyazawa M; Nishiuchi R; Kikkawa K
    Pediatr Int; 2016 Feb; 58(2):146-51. PubMed ID: 26190225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of risk scores for predicting intravenous immunoglobulin resistance in Taiwanese patients with Kawasaki disease.
    Huang CN; Wu FF; Chang YM; Huang HC; Lin MT; Wang JK; Wu MH
    J Formos Med Assoc; 2021 Oct; 120(10):1884-1889. PubMed ID: 33358267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inability of Asian risk scoring systems to predict intravenous immunoglobulin resistance and coronary lesions in Kawasaki disease in an Italian cohort.
    Fabi M; Andreozzi L; Corinaldesi E; Bodnar T; Lami F; Cicero C; Tchana B; Landini C; Sprocati M; Bigucci B; Balsamo C; Sogno Valin P; Di Fazzio G; Iughetti L; Valletta E; Marchetti F; Donti A; Lanari M
    Eur J Pediatr; 2019 Mar; 178(3):315-322. PubMed ID: 30499051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of the predictive validity of the combination of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio and other risk scoring systems for intravenous immunoglobulin (ivig)-resistance in Kawasaki disease.
    Takeshita S; Kanai T; Kawamura Y; Yoshida Y; Nonoyama S
    PLoS One; 2017; 12(5):e0176957. PubMed ID: 28542183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Formosa score and diagnostic sensitivity and specificity of four Asian risk scores for predicting intravenous immunoglobulin resistance in Kawasaki disease: a bivariate meta-analysis.
    Chiang WN; Huang PY; Kuo HC; Huang YH; Chang LS
    Front Cardiovasc Med; 2023; 10():1164530. PubMed ID: 37378410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Verification of Current Risk Scores for Kawasaki Disease in Korean Children.
    Shin J; Lee H; Eun L
    J Korean Med Sci; 2017 Dec; 32(12):1991-1996. PubMed ID: 29115081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors in IVIG-resistant Kawasaki disease and correlation with Japanese scoring systems - a study from Eastern India.
    Ahmed N; Pal P; Azad SM; Ghosh A; Banerjee P; Sarkar SD
    Clin Rheumatol; 2023 Jan; 42(1):145-150. PubMed ID: 36053472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of efficacy of six prediction models for intravenous immunoglobulin resistance in Kawasaki disease.
    Qian W; Tang Y; Yan W; Sun L; Lv H
    Ital J Pediatr; 2018 Mar; 44(1):33. PubMed ID: 29523168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of the Relationship Between Kobayashi, Sano, and Egami Criteria and Prevalence of Intravenous Immunoglobulin Resistance and Coronary Artery Aneurysm in Iranian Children with Kawasaki Disease.
    Shashaani N; Shiari R; Karimi A; Salehi S; Ghanaei R; Hassas Yeganeh M; Shiari S; Rahmani K; Javadi Parvaneh V
    Open Access Rheumatol; 2020; 12():187-192. PubMed ID: 32943952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TNF-α blockers for the treatment of Kawasaki disease in children.
    Yamaji N; da Silva Lopes K; Shoda T; Ishitsuka K; Kobayashi T; Ota E; Mori R
    Cochrane Database Syst Rev; 2019 Aug; 8(8):CD012448. PubMed ID: 31425625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of Four Scoring Systems in Predicting Intravenous Immunoglobulin Resistance in Children with Kawasaki Disease in a Children's Hospital in Beijing, North China.
    Song R; Yao W; Li X
    J Pediatr; 2017 May; 184():120-124. PubMed ID: 28043682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coronary Artery Complication in Kawasaki Disease and the Importance of Early Intervention : A Systematic Review and Meta-analysis.
    Chen S; Dong Y; Kiuchi MG; Wang J; Li R; Ling Z; Zhou T; Wang Z; Martinek M; Pürerfellner H; Liu S; Krucoff MW
    JAMA Pediatr; 2016 Dec; 170(12):1156-1163. PubMed ID: 27749951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is there an association between intravenous immunoglobulin resistance and coronary artery lesion in Kawasaki disease?-Current evidence based on a meta-analysis.
    Zheng X; Li J; Yue P; Liu L; Li J; Zhou K; Hua Y; Li Y
    PLoS One; 2021; 16(3):e0248812. PubMed ID: 33764989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacologic interventions for Kawasaki disease in children: A network meta-analysis of 56 randomized controlled trials.
    Lei WT; Chang LS; Zeng BY; Tu YK; Uehara R; Matsuoka YJ; Su KP; Lee PC; Cavalcante JL; Stubbs B; Lin PY; Wu YC; Hsu CW; Chen TY; Chen YW; Yeh PY; Sun CK; Tseng PT; Kao YH
    EBioMedicine; 2022 Apr; 78():103946. PubMed ID: 35306339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.